Welcome to PRECISE - a pan-Canadian diagnostic Network that has been established to better prepare Canada against emerging infectious diseases.
COVID-19 has highlighted critical gaps in the Canadian pandemic preparedness strategy, especially in the biomanufacturing sector, including diagnostics. Operationally, the lack of a Canadian diagnostic strategy has limited our ability to efficiently detect, track and trace COVID-19 early in the pandemic, hence hampering our onward response.
PRECISE is a collaborative network project with multiple partners. Our partners include:
Rapid detection of currently endemic and emerging pathogens/diseases in our communities.
Identification of novel pathogens and their variants, along with an understanding of the downstream host response in infected individuals.
Accelerate the development, validation and implementation of diagnostic tests and data analytics.
Collaboration among knowledge users, including policymakers, clinicians, scientists, industry, and local communities.
We're happy to announce the successful conclusion of our 2026 summer student internship program! Over the past few months, our students brought energy, curiosity, and fresh ideas to the team, and their contributions were a real asset to our program. To close out the summer, each student presented their work to the team at the 2026 Summer Student Symposium on Aug 18, 2026. The quality of the presentations were outstanding and at high standards. A special congratulations to our top 3 presentation winners, who managed to inch out ahead of their peers with their clear communication and polished delivery. Well done!
PRECISE has activated the clinical protocol to enroll Canadian patients exposed to and infected with the Andes Virus Hantavirus linked the MV Hondius cruise ship outbreak. PRECISE is collaborating with the World Health Organization to contribute data together with other global partners. With participants enrolled in Ontario and the study now extended to British Columbia, this work highlights PRECISE’s ability to rapidly respond to emerging infectious disease threats.
